Editorial Board for section 'Antibody-Based Therapeutics'
- Antibody Discovery and Engineering Section
- Antibody-Based Therapeutics Section
- Antibody-Based Diagnostics Section
- Humoral Immunity Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28041 Madrid, Spain
Interests: cancer Immunotherapy; bispecific antibodies; immunostimulatory antibodies; in situ secretion of antibodies
Interests: cancer Immunotherapy; bispecific antibodies; immunostimulatory antibodies; in situ secretion of antibodies
Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, UK
Interests: antibody drugs; antibody immunotherapy; cancer immunology; antibody effector functions; immunomodulatory antibodies; tumour microenvironment; Fc gamma receptors; macrophages; antibody selection, design and preclinical development
Interests: antibody drugs; antibody immunotherapy; cancer immunology; antibody effector functions; immunomodulatory antibodies; tumour microenvironment; Fc gamma receptors; macrophages; antibody selection, design and preclinical development
IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, 34298 Montpellier, France
Interests: oncoimmunology; immunotherapy; tumor microenvironment; tumor immunity, therapeutic antibodies
Interests: oncoimmunology; immunotherapy; tumor microenvironment; tumor immunity, therapeutic antibodies
1. The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 27232, USA
2. Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 27232, USA
Interests: antibody therapeutics; infectious diseases; viruses; antibody generation and development; biomarker development; biotechnology
Special Issues, Collections and Topics in MDPI journals
2. Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 27232, USA
Interests: antibody therapeutics; infectious diseases; viruses; antibody generation and development; biomarker development; biotechnology
Special Issues, Collections and Topics in MDPI journals
Aix-Marseille Université, CNRS, Inserm, Institut Paoli-Calmettes, CRCM, F-13009 Marseille, France
Interests: onco immunology; antibody engineering
Special Issues, Collections and Topics in MDPI journals
Interests: onco immunology; antibody engineering
Special Issues, Collections and Topics in MDPI journals
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
Interests: antibodies; therapeutic antibodies in cancer; autoantibodies and inflammation; Fc receptor function on dendritic cells
Interests: antibodies; therapeutic antibodies in cancer; autoantibodies and inflammation; Fc receptor function on dendritic cells
Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK
Interests: antibody immunotherapy; antibody therapeutics; Fc gamma receptors; tumour microenvironment
Special Issues, Collections and Topics in MDPI journals
Interests: antibody immunotherapy; antibody therapeutics; Fc gamma receptors; tumour microenvironment
Special Issues, Collections and Topics in MDPI journals
Antibody and Vaccine Group, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Tremona Road, Southampton SO16 6YD, UK
Interests: cancer immunotherapy; antibody structure and function; monoclonal antibody engineering; immunomodulating antibodies
Interests: cancer immunotherapy; antibody structure and function; monoclonal antibody engineering; immunomodulating antibodies
Hematology Division, Bergamo, Italy
Interests: functional analysis of therapeutic antibodies in vitro and in vivo; bispecific antibodies; hematological cancers; somatic cell therapy
Special Issues, Collections and Topics in MDPI journals
Interests: functional analysis of therapeutic antibodies in vitro and in vivo; bispecific antibodies; hematological cancers; somatic cell therapy
Special Issues, Collections and Topics in MDPI journals
1. Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany
2. Department for Oncology and Hematology, Hospital of the Canton of St. Gallen, 9007 St. Gallen, Switzerland
Interests: multiple myeloma; stem cell transplantation; antibody drug conjugates; immunotoxins and clinical application of antibodies
2. Department for Oncology and Hematology, Hospital of the Canton of St. Gallen, 9007 St. Gallen, Switzerland
Interests: multiple myeloma; stem cell transplantation; antibody drug conjugates; immunotoxins and clinical application of antibodies
National Institute for Biological Standards and Controls, Blanche Lane, South Mimms, Potters Bar, Herts EN6 3QG, UK
Interests: antibody immunotherapy; antibody engineering and optimisation; biosimilar safety and efficacy
Interests: antibody immunotherapy; antibody engineering and optimisation; biosimilar safety and efficacy
Translational Cancer Immunology and Immunotherapy, St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London SE1 9RT, UK
Interests: B cell responses in cancer; antibody engineering and glycoengineering; IgE class of antibodies in cancer; antibody Fc-mediated functions in cancer; cancer immunology; cancer immunotherapy; antibody-drug conjugates; melanoma; ovarian cancer; breast cancer; allergo-oncology; ADCC; ADCP; macrophages; monocytes; NK cells
Special Issues, Collections and Topics in MDPI journals
Interests: B cell responses in cancer; antibody engineering and glycoengineering; IgE class of antibodies in cancer; antibody Fc-mediated functions in cancer; cancer immunology; cancer immunotherapy; antibody-drug conjugates; melanoma; ovarian cancer; breast cancer; allergo-oncology; ADCC; ADCP; macrophages; monocytes; NK cells
Special Issues, Collections and Topics in MDPI journals
Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, 81377 Munich, Germany
Interests: antibodies; cancer immonotherapy; antibody engineering; monoclonal antibodies; bispecific antibodies; effector cell recruitment; NK cells; macrophages; immunology; phage display
Interests: antibodies; cancer immonotherapy; antibody engineering; monoclonal antibodies; bispecific antibodies; effector cell recruitment; NK cells; macrophages; immunology; phage display
Structural Biology, UCB, 216 Bath Road, Slough SL1 3WE, UK
Interests: therapeutic antibodies; antibody technology; antibody fragments; molecular dynamics
Special Issues, Collections and Topics in MDPI journals
Interests: therapeutic antibodies; antibody technology; antibody fragments; molecular dynamics
Special Issues, Collections and Topics in MDPI journals
Antibodytherapy Laboratory H02.315, Center for Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
Interests: antibody drugs; antibodies and Fc receptors in cancer; autoimmunedisease and infections; neutrophils; IgA; myeloid checkpoint inhibitors
Interests: antibody drugs; antibodies and Fc receptors in cancer; autoimmunedisease and infections; neutrophils; IgA; myeloid checkpoint inhibitors
Department of Medical Science, University of Turin and Fondazione Ricerca Molinette, 10123 Turin, Italy
Interests: antibody therapy; human myeloma; leukemia; IgG receptors; immune modulation
Special Issues, Collections and Topics in MDPI journals
Interests: antibody therapy; human myeloma; leukemia; IgG receptors; immune modulation
Special Issues, Collections and Topics in MDPI journals
Division of Biosciences, Institute of Structural and Molecular Biology, University College London, Darwin Building, Gower Street, London WC1E 6BT, UK
Interests: bioinformatics; computational biology; antibody sequence and structure; anti-body-based drugs; developability; antibody modelling
Interests: bioinformatics; computational biology; antibody sequence and structure; anti-body-based drugs; developability; antibody modelling
Functional Screening and Targeting in Cancer, Institut de Recherche en Cancérologie de Montpellier Inserm U1194, Université de Montpellier - ICM, Montpellier, France
Interests: cancer immunotherapy; antibody engineering; display; intracellular antibodies
Interests: cancer immunotherapy; antibody engineering; display; intracellular antibodies
Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Interests: complement; lung cancer and immunotherapy; Fc receptors; immunotherapy of cancer
Interests: complement; lung cancer and immunotherapy; Fc receptors; immunotherapy of cancer
Division of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-Universität zu Kiel, Kiel, Germany
Interests: antibody engineering; antibody-based immunotherapy; immune effector cell recruitment; bispecific antibodies; cancer immunotherapy
Special Issues, Collections and Topics in MDPI journals
Interests: antibody engineering; antibody-based immunotherapy; immune effector cell recruitment; bispecific antibodies; cancer immunotherapy
Special Issues, Collections and Topics in MDPI journals
OSE Immunotherapeutics, Nantes, France
Interests: immunotherapy; immuno-oncology; immuno-inflammation; T and B lymphocytes; macrophages; neutrophils; cytokine
Special Issues, Collections and Topics in MDPI journals
Interests: immunotherapy; immuno-oncology; immuno-inflammation; T and B lymphocytes; macrophages; neutrophils; cytokine
Special Issues, Collections and Topics in MDPI journals
School of Pharmacy, University of Waterloo, 10 Victoria St S, Kitchener, ON N2G 1C5, Canada
Interests: antibody; cancer therapeuty
Interests: antibody; cancer therapeuty
Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK
Interests: drug delivery; nanoparticles; conjugation; antibody; targeted delivery; single-domain antibodies; cancer
Interests: drug delivery; nanoparticles; conjugation; antibody; targeted delivery; single-domain antibodies; cancer
Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, 1881 East Road, Houston, TX 77054, USA
Interests: therapeutics cancers; antibody–drug conjugates (ADCs); next-generation ADCs; design, synthesis, and evaluation of novel branched chemical linkers for constructing multiloading ADCs; structural optimization of ADC linkers for high plasma stability and rapid drug release
Interests: therapeutics cancers; antibody–drug conjugates (ADCs); next-generation ADCs; design, synthesis, and evaluation of novel branched chemical linkers for constructing multiloading ADCs; structural optimization of ADC linkers for high plasma stability and rapid drug release
Antibody Engineering and Drug Discovery Group, MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, 131 Dong An Road, Shanghai 200032, China
Interests: monoclonal antibodies; antibody engineering; Fc receptors; immunotherapy of cancer; infectious diseases
Special Issues, Collections and Topics in MDPI journals
Interests: monoclonal antibodies; antibody engineering; Fc receptors; immunotherapy of cancer; infectious diseases
Special Issues, Collections and Topics in MDPI journals
Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China
Interests: biopharmaceutical development; cancer immunotherapy; bioprocess for antibody manufacturing; multi-specific immuno-hybrid protein synthesis; immunotoxins
Interests: biopharmaceutical development; cancer immunotherapy; bioprocess for antibody manufacturing; multi-specific immuno-hybrid protein synthesis; immunotoxins
Department of Immunology and Microbiology The Scripps Research Institute, La Jolla, CA 92037, USA
Interests: neutralizing antibodies; B cell responses; HIV; viruses; vaccines; antibody therapy; directed evolution; membrane lipid antibodies
Interests: neutralizing antibodies; B cell responses; HIV; viruses; vaccines; antibody therapy; directed evolution; membrane lipid antibodies
